INVESTMENT CASE INVESTMENT CASE INVESTMENT CASE INVESTMENT CASE

BFC Group-Healthcare Investment Banking

Empowering you to become the global leader

Time selection:
From
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
to
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
All cases
2024
  • 成都百裕
  • 领泰A
  • 天镜生物 赛诺菲
  • HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, listed on Nasdaq on April 29, 2022.
2023
  • 凯思凯迪A+
  • 维眸D2
  • 普莱 正大天晴
  • 普莱D
  • 柏全pre-A
2022
  • 邦顺 B
  • 爱萨尔B
  • 再极C+
  • 0729BridGene
  • 友芝友许可康哲
  • 信念医药C
  • 亚瑟医药A
  • 中因科技A
  • 量准A轮
  • 健适医疗
  • 国医通 A+
  • 壁辰
2021
  • 轶诺药业
  • OMNI
  • XGene
  • JSI B
  • IMPACT C+轮融资
  • KOBIOLABS 上海医药
  • 三诺 EOFLOW合资
  • 维立志博 C
  • Sinovent SINOMAB 授权云顶
  • 珃诺 B
  • 红云 B
  • KBP
  • LAEKNA
  • 康哲收购康乃馨
  • Hummingbird C
  • 泰励生物科技 A
  • BAROnova 许可
  • 北恒生物 B
  • BRATTEA B+
  • 欧莱雅
  • TL Pre-IPO
  • Luqa is a dermatology focused company that provides a broad range of high-end skin solutions, including prescription medicines, medical devices, medical aesthetic solutions and skin care products, that meets the diversified needs of consumers and market.
  • UCB商务咨询
  • 麦济生物 A+轮融资
2020
  • shanton B轮融资
  • CYBREXA B2轮融资
  • Advaccine B轮融资
  • HEXAELL B轮融资
  • MicuRx
  • KeChow Pharma is a China based global biotech company focused on novel small molecule drug discovery.
  • transgene股权出售
  • Thousand Oaks Pharma is an integrated CMC solution provider company.
  • 茵络医疗器械C轮融资
  • 江苏尼科医疗器械股权出售
  • 再极医药C轮融资
  • 欧莱雅
  • Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company that is focused on discovering and developing small molecule therapeutics for cancer.
  • 和心诺泰药业B轮融资
  • ELITE
  • Zentera A轮融资
  • Med-Sonics股权交易+产品授权许可
  • Leap Therapeutics (Nasdaq:LPTX) is a U.S based, clinical-stage biotechnology company focused on developing and commercializing targeted immuno-oncology therapeutics.
  • 智核生物B轮融资
  • Aravive Inc (Nasdaq: ARAV) is a US-based clinical-stage oncology company developing transformative therapeutics.
2019
  • Hummingbird B轮融资
  • SUN产品授权许可
  • 雅创医药B轮融资
  • 华脉泰科D轮融资
  • TCL医疗 Pre-A轮融资
  • sparc产品授权
  • VIROGIN B轮融资
  • 再极医药B轮融资
  • 三叶草
  • SUN产品授权许可7个仿制药
  • SUN产品授权许可环孢菌素A
  • Transcenta is equipped with a senior team with extensive global industrial experience in biologics-based therapeutics discovery and development, and fully integrated in-house capabilities in biologic therapeutics discovery, development and manufacturing.
2018
  • 仁度生物C轮融资
  • 宜明昂科 A轮融资
  • 钧济医学收购
  • 泽璟制药收购Gensun
  • 健耕医药股权投资
  • 友芝友生物制药B轮融资
  • IMPACT C轮融资
2017
  • RESVERLOGIX 8700万加元投资
  • RESERLOGIX美国期权交易
  • 摩尔齿科C轮融资
  • OMNI C轮融资
  • Eutilex is a Korea-based, clinical-stage biopharmaceutical company focused on the development of anti-tumor T cell and antibody therapeutics for the treatment of cancers and autoimmune diseases.
  • 健耕医药D+轮融资
  • 畅溪A轮融资
  • 亚虹医药
  • DIAMEDICA
  • 茵络医疗器械B轮融资
  • KBP is a globally integrated Chinese biotech company. KBP has its clinical development center in US; Its R&D and CMC center is based in Jinan, China.
2016
  • Genext is the leading domestic transplant company in China with a full product coverage from transplant therapeutics, IVD to medical devices.
  • MicuRx C轮融资
  • Orbiepharm股权出售
2015
  • 奥精医药D轮融资
  • RESVERLOGIX 5000万融资+授权许可
  • UPPER B轮融资
2014
  • THE MEDICINES COMPANY传品授权许可SCICLONE
  • 远大医药收购JM
  • DiaCarta B轮融资
  • AGENIX HBV资产剥离
2013
  • IPSEN
  • REALTON C轮融资
  • Orbiepharm收购NEW HORIZON
2012
  • EDAN商务拓展
  • 科美生物商务拓展
  • ICON收购北京威茨医疗
  • IPSEN
  • STALLERGENES战略咨询
  • Ironwood产品授权许可阿斯利康
2011
  • IPSEN